Clinical trials demonstrate average weight reductions of approximately 15% with semaglutide 2.4 mg (STEP 1 trial) and 20-22.5% with tirzepatide 10-15 mg (SURMOUNT-1 trial) over 68-72 weeks
70+ Add-Ons to Keep You Fueled All Day Breakfast Protein packed, on-the-go bites Shakes & Smoothies To have while you're on-the-go Snacks Indulge & Stay on Track Extra Proteins Add extra proteins to your meal Get 50% Off + Free Breakfast for 1 Year * Get 50% Off + Free Breakfast for 1 Year * Common Questions About Our Calorie Smart Meals
O ensaio incluiu pessoas sem diabetes, com IMC mdio de 40,4kg/m, e ambas as doses atingiram todos os desfechos primrios e secundrios: reduo de peso, diminuio da dor (at 75,8% de reduo no escore de dor WOMAC) e melhora da funo fsica
Recognising Symptoms of Gallstones During GLP-1 Treatment Many individuals with gallstones remain asymptomatic, with stones discovered incidentally during imaging for unrelated conditions
Jenkins DJ, Wolever TM, Collier GR, Ocana A, Rao AV, Buckley G, et al
BPC-157 - (gut-brain axis)